Garofalo Health Care S.p.A. (GHC)
MTA
Closed
Aug 24, 2026
Day's Range
5.6052 wk Range
4.34Overview - GHC - Garofalo Health Care S.p.A.
Key Statistics
Valuation
Enterprise Value
724.56M
P/E (Trailing)
‪23.50‬
P/E (Forward)
‪18.55‬
PEG Ratio
‪-1.40‬
Price / Sales (TTM)
‪1.01‬
Price / Book
‪1.46‬
EV / EBITDA
‪9.87‬
Profitability
Gross Margin
‪84.26%‬
Profit Margin
‪4.44%‬
Operating Margin
‪11.77%‬
Return on Assets
‪3.49%‬
Return on Equity
‪6.21%‬
Ownership
Shares Outstanding
88.29M
Float
24.88M
Held by Insiders
‪68.28%‬
Held by Institutions
‪10.47%‬
Price stats
Beta
‪0.36‬
50-Day Avg
‪5.48‬
200-Day Avg
‪5.31‬
Dividends
Payout Ratio
‪35.70%‬
Frequency
Annual
Analyst Consensus
1 analysts
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GHC - Garofalo Health Care S.p.A.
Peers - GHC - Garofalo Health Care S.p.A.
Peer Comparison
Compared with companies in Medical Care Facilities listed on MTA.
Profile Summary - GHC - Garofalo Health Care S.p.A.
About
Garofalo Health Care S.p.A. is a leading Italian private accredited healthcare group, listed on the Euronext STAR segment of the Italian Stock Exchange and headquartered in Rome. Founded in the 1950s by surgeon Raffaele Garofalo, it has grown into the first and only publicly listed private healthcare company in Italy,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
